Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 02, 2016 08:00 ET | Source: Auris Medical AG

Auris Medical to Present at the Jefferies 2016 Healthcare Conference on Thursday, June 9

ZUG, Switzerland, June 2, 2016 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
May 11, 2016 06:30 ET | Source: Auris Medical AG

Auris Medical Provides Business Update and Reports First Quarter 2016 Financial Results

Key Opinion Leader meeting focused on AM-101 scheduled for June 14 in New York City Top-line results from pivotal TACTT2 trial of AM-101 in acute inner ear tinnitus expected in August ...
May 04, 2016 08:00 ET | Source: Auris Medical AG

Auris Medical to Announce First Quarter 2016 Financial Results and Host Conference Call on Wednesday, May 11, 2016

Zug, Switzerland, May 4, 2016 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
April 05, 2016 06:30 ET | Source: Auris Medical AG

Auris Medical to Present at the 15th Annual Needham Healthcare Conference on Tuesday, April 12

Zug, Switzerland, April 5, 2016 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology,...
March 30, 2016 06:30 ET | Source: Auris Medical AG

Auris Medical Completes Enrollment of TACTT2 Phase 3 Trial of AM-101 in Acute Inner Ear Tinnitus

Top-line results from pivotal TACTT2 trial expected in August 2016 Zug, Switzerland, March 30, 2016 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing...
March 14, 2016 06:30 ET | Source: Auris Medical AG

Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2015 Financial Results

AM-101 Phase 3 pivotal trial (TACTT2) in acute inner ear tinnitus approaching completion of enrollment 2015 operating expenses of CHF 30.9 million at low end of previous full year guidance ...
March 02, 2016 06:00 ET | Source: Auris Medical AG

Auris Medical to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on Monday, March 14, 2016

Auris Medical News Release Auris Medical to Announce Fourth Quarter and Full Year 2015 Financial Results and Host Conference Call on Monday, March 14, 2016 Zug, Switzerland, March 2, 2016 - Auris...
February 18, 2016 09:00 ET | Source: Auris Medical AG

Auris Medical to Host Key Opinion Leader Meeting and Webcast Focused on Acute Sensorineural Hearing Loss on February 26 in New York City

Zug, Switzerland, February 18, 2016 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
February 05, 2016 08:00 ET | Source: Auris Medical AG

Auris Medical to Present at the 2016 Leerink Global Healthcare Conference on Thursday, February 11

Zug, Switzerland, February 5, 2016 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...
November 13, 2015 08:05 ET | Source: Auris Medical AG

Auris Medical Announces Enrollment of First Patient in HEALOS Study of AM-111 in Treatment of Idiopathic Sudden Sensorineural Hearing Loss

ZUG, Switzerland, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in...